Core Viewpoint - Alps Group Inc successfully completed its business combination with Globalink Investment Inc, marking a significant milestone as it prepares to list on the Nasdaq under the symbol "ALPS" on October 31, 2025 [1][4]. Business Combination Details - The business combination was executed under an Amended and Restated Merger Agreement, with multiple amendments leading up to the final agreement [2]. - The transaction involved a two-step merger process: a Redomestication Merger and an Acquisition Merger, resulting in Alps Group as the surviving publicly traded entity [3]. Trading and Valuation - Following the closing, Alps Group's ordinary shares will begin trading on Nasdaq, with an estimated enterprise value of approximately US$1.6 billion for the combined company [4]. Leadership and Governance - Post-closing, the headquarters of Alps Group will be in Kuala Lumpur, Malaysia, with Dr. Tham Seng Kong serving as the Chief Executive Officer and Chairman of the Board [5]. Strategic Vision - The CEO emphasized the mission to redefine healthcare through predictive, preventive, and precision medicine, aiming to make advanced healthcare accessible globally [6]. - The company plans to develop its BioValley initiative, a biotechnology hub to foster collaboration in the biotech ecosystem [8]. Financial Support - In connection with the business combination, Alps Group secured approximately US$3.1 million from PIPE Investors to support its growth strategy and working capital needs [6].